Beyond the Tumor: Invasive Fungal Infection Unveiled in HER2-Positive Breast Cancer Patient Mimicking Disease Relapse

1. Tufail M, Wu C. Cancer Statistics in Pakistan From 1994 to 2021: Data From Cancer Registry. JCO Clin Cancer Inform. 2023;7. doi:10.1200/CCI.22.00142 TufailM WuC Cancer Statistics in Pakistan From 1994 to 2021: Data From Cancer Registry JCO Clin Cancer Inform 2023 7 10.1200/CCI.22.00142 Open DOISearch in Google Scholar

2. Lei S, Zheng R, Zhang S, et al. Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (Lond). 2021;41(11):1183–1194. doi:10.1002/cac2.12207 LeiS ZhengR ZhangS Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020 Cancer Commun (Lond). 2021 41 11 1183 1194 10.1002/cac2.12207 Open DOISearch in Google Scholar

3. Vaz-Luis I, Winer EP, Lin NU. Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?. Ann Oncol. 2013;24(2):283–291. doi:10.1093/annonc/mds286 Vaz-LuisI WinerEP LinNU Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?. Ann Oncol. 2013 24 2 283 291 10.1093/annonc/mds286 Open DOISearch in Google Scholar

4. Arteaga CL, Sliwkowski MX, Osborne CK, et al. Treatment of HER2-positive breast cancer: current status and future perspectives. Nat Rev Clin Oncol. 2011;9(1):16–32. doi:10.1038/nrclinonc.2011.177 ArteagaCL SliwkowskiMX OsborneCK Treatment of HER2-positive breast cancer: current status and future perspectives Nat Rev Clin Oncol. 2011 9 1 16 32 10.1038/nrclinonc.2011.177 Open DOISearch in Google Scholar

5. Baddley JW, Andes DR, Marr KA, et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis. 2010;50(12):1559–1567. doi:10.1086/652768 BaddleyJW AndesDR MarrKA Factors associated with mortality in transplant patients with invasive aspergillosis Clin Infect Dis. 2010 50 12 1559 1567 10.1086/652768 Open DOISearch in Google Scholar

6. Slamon DJ, et al. Adjuvant Trastuzumab in HER2-Positive Breast Cancer. N Engl J Med. 2011;365(14):1273–1283. SlamonDJ Adjuvant Trastuzumab in HER2-Positive Breast Cancer N Engl J Med. 2011 365 14 1273 1283 Search in Google Scholar

7. O’Shaughnessy J, Gradishar W, O’Regan R, Gadi V. Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics. Clin Breast Cancer. 2023;23(4):350–362. doi:10.1016/j.clbc.2023.03.007 O’ShaughnessyJ GradisharW O’ReganR GadiV Risk of Recurrence in Patients With HER2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics Clin Breast Cancer. 2023 23 4 350 362 10.1016/j.clbc.2023.03.007 Open DOISearch in Google Scholar

8. Peng L, Zhang Z, Zhao D, et al. Discordance in ER, PR, HER2, and Ki-67 Expression Between Primary and Recurrent/Metastatic Lesions in Patients with Primary Early Stage Breast Cancer and the Clinical Significance: Retrospective Analysis of 75 Cases. Pathol Oncol Res. 2021;27:599894. doi:10.3389/pore.2021.599894 PengL ZhangZ ZhaoD Discordance in ER, PR, HER2, and Ki-67 Expression Between Primary and Recurrent/Metastatic Lesions in Patients with Primary Early Stage Breast Cancer and the Clinical Significance: Retrospective Analysis of 75 Cases Pathol Oncol Res. 2021 27 599894 10.3389/pore.2021.599894 Open DOISearch in Google Scholar

9. Patanaphan V, Salazar OM, Risco R. Breast cancer: metastatic patterns and their prognosis. South Med J. 1988;81(9): 1109–1112. PatanaphanV SalazarOM RiscoR Breast cancer: metastatic patterns and their prognosis South Med J. 1988 81 9 1109 1112 Search in Google Scholar

10. Bai X, Luo J. Invasive Candidiasis in Patients with Solid Tumors: A Single-Center Retrospective Study. Int J Gen Med. 2023;16:2419–2426. doi:10.2147/IJGM.S411 BaiX LuoJ Invasive Candidiasis in Patients with Solid Tumors: A Single-Center Retrospective Study Int J Gen Med. 2023 16 2419 2426 10.2147/IJGM.S411 Open DOISearch in Google Scholar

11. Mousset S, Buchheidt D, Heinz W, et al. Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2014;93(1):13–32. doi:10.1007/s00277-013-1867-1 MoussetS BuchheidtD HeinzW Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) Ann Hematol. 2014 93 1 13 32 10.1007/s00277-013-1867-1 Open DOISearch in Google Scholar

12. Tzeng Y-L, et al. Strategies to Improve Access to Targeted Therapy in Low-Resource Settings. Global Health Action. 2019;12(1):1584520. TzengY-L Strategies to Improve Access to Targeted Therapy in Low-Resource Settings Global Health Action. 2019 12 1 1584520 Search in Google Scholar